Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0600

+16.5%

3:10 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Howard Williams who wrote (11453)	7/23/2012 11:48:25 AM
From: Mammon	1 Recommendation Read Replies (2) of 13111

interesting article on accelerated approval of onyx's multiple myeloma drug: fiercebiotech.com From the article: "An approval would also encourage more drug developers to make their case for cancer drugs on Phase II data, significantly changing the value of these products if regulators appear more willing to take these risks among the sickest patients. And that process could be further accelerated by the new PDUFA bill that's about to clear Congress."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next